A2 Milk hails research showing its protein variant has different digestive characteristics

Mon, 11 Aug 2014

By Jonathan Underhill Aug. 11 (BusinessDesk) - A2 Milk, which is facing copycat health claims about the A2 beta-casein protein variant in its largest market of Australia, has released a study suggesting the protein doesn't provoke digestive discomfort the way the more common A1 variant does. The Curtin University study, funded by NZX-listed A2 Milk and published in the European Journal of Clinical Nutrition, is the first clinical trial of A1 and A2 milk proteins on human digestion. A2 Milk markets its products as potentially being benefic...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets FREE
Contact Energy kicks off earnings season
Staff reporters | Mon, 15 Aug 2022

Contact Energy kicked off earnings season today, telling shareholders its annual profit had dipped 2.6% from 2021, and a $300 million investment into a new geothermal power station is on the way.

Transport
Aucklanders must get out of cars, onto public transport, says emissions plan
Oliver Lewis | Mon, 15 Aug 2022

Auckland council has unveiled its pathway to reduced transport emissions.

Law & Regulation
Address climate change now, supreme court told
Victoria Young | Mon, 15 Aug 2022

Fonterra, Genesis and others face climate change activist Mike Smith.

Sponsored
Communication the barrier to ‘human firewall’ technology

Communication is the barrier to New Zealand adopting the global Zero Trust cybersecurity strategy, says a new survey.

Sponsored
A clearer path to the cloud

Step-by-step cloud transition can bring benefits, experts say.